Marzi Simona, Piludu Francesca, Sanguineti Giuseppe, Marucci Laura, Farneti Alessia, Terrenato Irene, Pellini Raul, Benevolo Maria, Covello Renato, Vidiri Antonello
Medical Physics Laboratory, Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144 Rome, Italy.
Radiology and Diagnostic Imaging Department, Regina Elena National Cancer Institute, Via Elio Chianesi 53, 00144 Rome, Italy.
Eur J Radiol. 2017 Jul;92:93-102. doi: 10.1016/j.ejrad.2017.05.002. Epub 2017 May 2.
To investigate the predictive role of Intravoxel Incoherent Motion Diffusion-Weighted Imaging (IVIM-DWI) parameters on cervical nodal response to chemo-radiotherapy (CRT) of head and neck squamous cell carcinoma (HNSCC).
Patients with pathologically confirmed HNSCC were included in the present prospective study, having at least one positive cervical lymph node (LN). They received concomitant CRT and underwent three serial IVIM-DWI investigations: before, at mid-treatment and after treatment completion. Tissue diffusion coefficient D, perfusion-related diffusion coefficient D* and perfusion fraction f were calculated by a bi-exponential fit. The two-sided Mann-Whitney rank test was used to compare the imaging parameters of patients with regional failure (RF) and regional control (RC). A p value lower than 0.05 was considered to be statistically significant.
Thirty-four patients were accrued. Twenty-four out of 34 LN (70.6%) showed persistent RC after a median follow-up time of 27.6 months (range: 12.0-50.2 months), while ten cases of RF (29.4%) were confirmed with a median time of 6.8 months (range: 1.5-19.5 months). Patients with RC showed significantly lower pre-treatment D values compared to the RF patients (p=0.038). At mid-treatment, the patients with RF showed significantly higher D values (p=0.025), and exhibited larger percent reductions in f and the product D*×f from the baseline (p=0.008 and <0.001, respectively). No additional information was provided by the examination at the end of treatment.
Pre-treatment and mid-treatment IVIM-DWI showed potential for prediction of treatment response of cervical LN in HNSCC patients.
探讨体素内不相干运动扩散加权成像(IVIM-DWI)参数对头颈部鳞状细胞癌(HNSCC)颈部淋巴结对放化疗(CRT)反应的预测作用。
本前瞻性研究纳入病理确诊的HNSCC患者,这些患者至少有一个阳性颈部淋巴结(LN)。他们接受同步放化疗,并进行了三次连续的IVIM-DWI检查:治疗前、治疗中期和治疗结束后。通过双指数拟合计算组织扩散系数D、灌注相关扩散系数D*和灌注分数f。采用双侧曼-惠特尼秩和检验比较区域失败(RF)和区域控制(RC)患者的成像参数。p值低于0.05被认为具有统计学意义。
共纳入34例患者。34个LN中的24个(70.6%)在中位随访时间27.6个月(范围:12.0 - 50.2个月)后显示持续的RC,而10例RF(29.4%)在中位时间6.8个月(范围:1.5 - 19.5个月)得到证实。与RF患者相比,RC患者治疗前的D值显著更低(p = 0.038)。在治疗中期,RF患者的D值显著更高(p = 0.025),并且f和D*×f乘积从基线的降低百分比更大(分别为p = 0.008和<0.001)。治疗结束时的检查未提供额外信息。
治疗前和治疗中期的IVIM-DWI显示出预测HNSCC患者颈部LN治疗反应的潜力。